Cite
Disseminated Mucormycosis in Immunocompromised Children: Are New Antifungal Agents Making a Difference? A Multicenter Retrospective Study.
MLA
Elitzur, Sarah, et al. “Disseminated Mucormycosis in Immunocompromised Children: Are New Antifungal Agents Making a Difference? A Multicenter Retrospective Study.” Journal of Fungi, vol. 7, no. 3, Mar. 2021, pp. 1–13. EBSCOhost, https://doi.org/10.3390/jof7030165.
APA
Elitzur, S., Fischer, S., Arad-Cohen, N., Barg, A., Ben-Harosh, M., Danino, D., Elhasid, R., Gefen, A., Gilad, G., Levy, I., Shachor-Meyouhas, Y., Weinreb, S., Izraeli, S., & Barzilai-Birenboim, S. (2021). Disseminated Mucormycosis in Immunocompromised Children: Are New Antifungal Agents Making a Difference? A Multicenter Retrospective Study. Journal of Fungi, 7(3), 1–13. https://doi.org/10.3390/jof7030165
Chicago
Elitzur, Sarah, Salvador Fischer, Nira Arad-Cohen, Assaf Barg, Miriam Ben-Harosh, Dana Danino, Ronit Elhasid, et al. 2021. “Disseminated Mucormycosis in Immunocompromised Children: Are New Antifungal Agents Making a Difference? A Multicenter Retrospective Study.” Journal of Fungi 7 (3): 1–13. doi:10.3390/jof7030165.